Dermatology

Julie A Moore MD

Accepts Medicare (pay less out of pocket)

Group Affiliations

MOORE DERMATOLOGY SC

Address

501 W N Ave,

Suite 103,

Melrose Park 60160-1603, IL

+2 more locations

Phone

(708) 450-5086

About Dr. Julie A Moore

With a distinguished career spanning since 1986 , Dr. Julie Moore has established herself as a respected Dermatology specialist. A graduate of Creighton University School Of Medicine, She is known for her comprehensive approach to patient care and dedication to medical excellence. Located at 501 W N Ave, Melrose Park, IL 60160-1603, Dr. Moore's practice offers telehealth services and welcomes new patients. For appointments, please call (708) 450-5086.

Details

Specialty

Dermatology

Gender

F

Medical School

Creighton University School Of Medicine

Graduation Year

1986

Offers Telehealth Services

Yes

Accepts Medicare Assignment

Yes

Facility / Group Affiliations

Facility Type

Group

Group Name

MOORE DERMATOLOGY SC

Member Count

2

Accepts Medicare Assignment

Y

Quality Payment Program (QPP) Performance

MIPS Measure

Provide Education Opportunities for New Clinicians

Attestation

Yes

MIPS Measure

Integration of patient coaching practices between visits

Attestation

Yes

MIPS Measure

Financial Navigation Program

Attestation

Yes

MIPS Measure

Tobacco use

Attestation

Yes

MIPS Measure

Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop

Attestation

Yes

MIPS Measure

Care transition standard operational improvements

Attestation

Yes

MIPS Measure

Care coordination agreements that promote improvements in patient tracking across settings

Attestation

Yes

MIPS Measure

Regular training in care coordination

Attestation

Yes

MIPS Measure

Implementation of documentation improvements for practice/process improvements

Attestation

Yes

MIPS Measure

Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record

Attestation

Yes

MIPS Measure

Implementation of improvements that contribute to more timely communication of test results

Attestation

Yes

MIPS Measure

Use of telehealth services that expand practice access

Attestation

Yes

MIPS Measure

Consulting AUC Using Clinical Decision Support when Ordering Advanced

Attestation

Yes

MIPS Measure

Use of Patient Safety Tools

Attestation

Yes

MIPS Measure

Preventive Care and Screening: Influenza Immunization

Attestation

No

MIPS Measure

Pneumococcal Vaccination Status for Older Adults

Attestation

No

MIPS Measure

Documentation of Current Medications in the Medical Record

Attestation

No

MIPS Measure

Melanoma: Continuity of Care Recall System

Attestation

No

MIPS Measure

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Attestation

No

MIPS Measure

Biopsy Follow-Up

Attestation

No

MIPS Measure

Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier

Attestation

No

MIPS Measure

Psoriasis: Clinical Response to Systemic Medications

Attestation

No

MIPS Measure

e-Prescribing

Attestation

No

MIPS Measure

Query of the Prescription Drug Monitoring Program (PDMP)

Attestation

Yes

MIPS Measure

Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion

Attestation

Yes

MIPS Measure

Support Electronic Referral Loops By Sending Health Information Exclusion

Attestation

Yes

MIPS Measure

ONC Direct Review Attestation

Attestation

Yes

MIPS Measure

Provide Patients Electronic Access to Their Health Information

Attestation

No

MIPS Measure

Clinical Data Registry Reporting

Attestation

Yes

MIPS Measure

Security Risk Analysis

Attestation

Yes

MIPS Measure

Clinical Data Registry Reporting for Multiple Registry Engagement

Attestation

Yes

Clinician Utilization Performance Scores

Tangential biopsy of single skin lesion

Practice State: IL

Line Service Count: 302

Beneficiary Count: 278

Tangential biopsy of additional skin lesion

Practice State: IL

Line Service Count: 59

Beneficiary Count: 51

Destruction of skin growth

Practice State: IL

Line Service Count: 452

Beneficiary Count: 358

Destruction of 2-14 skin growths

Practice State: IL

Line Service Count: 1070

Beneficiary Count: 245

Destruction of up to 14 skin growths

Practice State: IL

Line Service Count: 118

Beneficiary Count: 103

Pathology examination of tissue using a microscope, intermediate complexity

Practice State: IL

Line Service Count: 328

Beneficiary Count: 247

Injection beneath the skin or into muscle for therapy, diagnosis, or prevention

Practice State: IL

Line Service Count: 29

Beneficiary Count: 27

Injection, triamcinolone acetonide, not otherwise specified, 10 mg

Practice State: IL

Line Service Count: 197

Beneficiary Count: 71

Locations

501 W N Ave
Suite 103
Melrose Park, IL 60160 -1603
Phone: (708) 450-5086

Get Directions

701 W N Ave

Melrose Park, IL 60160 -1612
Phone: (708) 681-3200

Get Directions